Jonathan Poole, Chief Financial Officer at GENOCEA BIOSCIENCES, INC. (GNCA), bought 7,000 shares at $3.34 ($23K) on 2016-11-07, disclosed to the SEC on 2016-11-09.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| GNCA | BUY | 2016-05-10 | $16K | — | Filing → |